Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.
The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.
Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
Many people use over-the-counter remedies to ease flu symptoms, but people with a common health condition should take care ...
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
The expert continued: " If your blood pressure is within a healthy range and you have no heart-related concerns, short-term use of decongestants as directed is generally safe. However, for individuals ...